Low von Willebrand factor—unraveling an enigma wrapped in a conundrum
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.08.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von James S O'Donnell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; National Coag…. Hauptthemen laut MEDLINE: Hemorrhage, von Willebrand Factor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Science Foundation Ireland.
Abstract (Originalsprache)
The 2021 ASH ISTH NHF WFH guidelines recommendation that patients with von Willebrand factor (VWF) levels of 30 to 50 IU/dL and an increased bleeding phenotype be categorized as type 1 von Willebrand disease (VWD) rather than Low VWF has proved controversial. However, in support of that decision, recent data have demonstrated that individuals with partial quantitative VWF deficiency exhibit an age-dependent evolving phenotype and confirmed that Low VWF represents a subgroup within heterogeneous type 1 VWD. Nonetheless, type 1 VWD heterogeneity continues to pose significant diagnostic challenges. In this Forum article, we address outstanding issues critical to preventing the inappropriate overdiagnosis of type 1 VWD while maximizing access to healthcare and minimizing diagnostic delays. In addition, we propose an algorithm for type 1 VWD diagnosis. This algorithm pays special attention to individuals with plasma VWF levels in the 30 to 50 IU/dL range who have no or minimal bleeding history and have not yet been exposed to significant hemostatic challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; National Coagulation Centre, St James's Hospital, Dublin, Ireland; Irish-Australian…
- Irish-Australian Blood Collaborative (IABC) Network; Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, Western Australia, Australia.
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Förderung
- NHLBI NIH HHS
- Science Foundation Ireland
Zitieren
APA
O'Donnell, J. S., Baker, R. I., & Atiq, F. (2024). Low von Willebrand factor—unraveling an enigma wrapped in a conundrum. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.08.015
Vancouver
O'Donnell JS, Baker RI, Atiq F. Low von Willebrand factor—unraveling an enigma wrapped in a conundrum. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.08.015
BibTeX
@article{ODonnell2024,
author = {O'Donnell, James S and Baker, Ross I and Atiq, Ferdows},
title = {Low von Willebrand factor—unraveling an enigma wrapped in a conundrum},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.08.015}
}
EUVIMED